Exodus Point Capital Management, LP Repligen Corp Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Repligen Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 95,931 shares of RGEN stock, worth $15.4 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
95,931
Previous 30,793
211.54%
Holding current value
$15.4 Million
Previous $3.88 Million
267.75%
% of portfolio
0.09%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.22 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.03 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$812 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$261 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$229 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.93B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....